FLOVENT: GOING, GONE!

Background:

Flovent is an inhaled corticosteroid asthma controller medicine that is widely used to prevent asthma attacks.  It is administered using an Metered Dose inhaler (MDI).

The company that makes Flovent, GlaxoSmithKline, has announced that it will be discontinuing Flovent as of January 1, 2024.  They are replacing it with a generic equivalent, Fluticasone.

This replacement will come in the same strengths (44, 110, and 200 mcg per puff) delivered by an MDI.

Problem:

The problem is that many health insurance policies may not cover this new generic equivalent.  If you run into this, you will need to be switched to another formulation or brand of inhaled corticosteroid that is covered by your insurance plan.

Solutions:

For adults, there are a number of alternatives but there are fewer choices for children.  To help out, I have posted this equivalent dosing chart as an aide to finding the right medicine.  This information is from legitimate, nationally regarding organizations.  Feel free to share it with your doctor if there is any uncertainty about the best medication for your child.

As always, Asthmaniac is ready to help out, just grab an appointment and lets talk!

#asthmacontrolnow
#telemedicineasthmacare
#backpocketasthmadoc
#asthmaactionplan
#asthmacontroltest
#asthmacontroller
#rescueinhaler
#asthmacovid19
#childrenandasthma
#eprescription
#easthma
#peakexpiratoryflow
#peakflowmeter
#asthmaniac